Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1–6 months of age: A Randomized Controlled Trial
- 1 February 2012
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 65 (2), 231-238
- https://doi.org/10.1016/j.phrs.2011.11.016
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Complete Genome Sequence of Lactobacillus fermentum CECT 5716, a Probiotic Strain Isolated from Human MilkJournal of Bacteriology, 2010
- Incidence of infectious diseases in infants fed follow‐on formula containing synbiotics: an observational studyActa Paediatrica, 2010
- Prebiotics and probiotics; modifying and mining the microbiotaPharmacological Research, 2010
- Safety Assessment ofLactobacillus fermentumCECT5716, a probiotic strain isolated from human milkJournal of Dairy Research, 2009
- Maternal breast‐milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic diseaseClinical & Experimental Allergy, 2007
- The CUPDAY Study: prebiotic‐probiotic milk product in 1–3‐year‐old children attending childcare centresActa Paediatrica, 2007
- Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double‐blind, randomized trialJournal of Human Nutrition and Dietetics, 2006
- Human milk is a source of lactic acid bacteria for the infant gutThe Journal of Pediatrics, 2003
- Whey Predominant, Whey Modified Infant Formula with Protein/energy Ratio of 1.8 g/100 kcal: Adequate and Safe for Term Infants From Birth to Four MonthsJournal of Pediatric Gastroenterology and Nutrition, 2002
- A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian childrenThe Journal of Pediatrics, 1999